Moelans CB - Search Results

1

Promoter hypermethylation in ductal carcinoma in situ of the male breast.

Vermeulen MA, van Deurzen CHM, Doebar SC, de Leng WWJ, Martens JWM, van Diest PJ, Moelans CB. Vermeulen MA, et al. Among authors: moelans cb. Endocr Relat Cancer. 2019 Jun;26(6):575-584. doi: 10.1530/ERC-18-0485. Endocr Relat Cancer. 2019. PMID: 30921768

2

HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization.

Moelans CB, de Weger RA, van Blokland MT, Ezendam C, Elshof S, Tilanus MG, van Diest PJ. Moelans CB, et al. Cell Oncol. 2009;31(1):1-10. doi: 10.3233/clo-2009-0461. Cell Oncol. 2009. PMID: 19096145 Free PMC article.

3

HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.

Moelans CB, de Weger RA, Ezendam C, van Diest PJ. Moelans CB, et al. BMC Cancer. 2009 Jan 5;9:4. doi: 10.1186/1471-2407-9-4. BMC Cancer. 2009. PMID: 19123950 Free PMC article.

4

Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification.

Moelans CB, de Weger RA, van Diest PJ. Moelans CB, et al. Breast Cancer Res Treat. 2010 Feb;120(1):1-7. doi: 10.1007/s10549-009-0539-2. Epub 2009 Sep 18. Breast Cancer Res Treat. 2010. PMID: 19760503

5

Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer.

Moelans CB, de Weger RA, van Blokland MT, van der Wall E, van Diest PJ. Moelans CB, et al. Mod Pathol. 2010 Jan;23(1):62-70. doi: 10.1038/modpathol.2009.136. Epub 2009 Sep 18. Mod Pathol. 2010. PMID: 19767729 Free article.

6

Validation of a fully automated HER2 staining kit in breast cancer.

Moelans CB, Kibbelaar RE, van den Heuvel MC, Castigliego D, de Weger RA, van Diest PJ. Moelans CB, et al. Cell Oncol. 2010;32(1-2):149-55. doi: 10.3233/CLO-2010-0514. Cell Oncol. 2010. PMID: 20203372 Free PMC article.

7

Multiplex ligation-dependent probe amplification to detect HER2 amplification in breast cancer: new insights in optimal cut-off value.

Moelans CB, de Weger RA, van Diest PJ. Moelans CB, et al. Cell Oncol. 2010 Jan 1;32(4):311-2. doi: 10.3233/CLO-2009-0502. Cell Oncol. 2010. PMID: 20442492 Free PMC article. No abstract available.

8

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.

Moelans CB, de Weger RA, Monsuur HN, Vijzelaar R, van Diest PJ. Moelans CB, et al. Mod Pathol. 2010 Jul;23(7):1029-39. doi: 10.1038/modpathol.2010.84. Epub 2010 May 14. Mod Pathol. 2010. PMID: 20473280 Free article.

9

ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.

Moelans CB, Monsuur HN, de Pinth JH, Radersma RD, de Weger RA, van Diest PJ. Moelans CB, et al. Anal Cell Pathol (Amst). 2010;33(1):13-8. doi: 10.3233/ACP-CLO-2010-0527. Anal Cell Pathol (Amst). 2010. PMID: 20966540 Free PMC article.

10

Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.

Moelans CB, de Weger RA, Monsuur HN, Maes AH, van Diest PJ. Moelans CB, et al. Anal Cell Pathol (Amst). 2010;33(3):165-73. doi: 10.3233/ACP-CLO-2010-0546. Anal Cell Pathol (Amst). 2010. PMID: 20978320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters